These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 18197560)
1. Importance of mechanistic drug metabolism studies in support of drug discovery: A case study with an N -sulfonylated dipeptide VLA-4 antagonist in rats. Tang W; Stearns RA; Chen Q; Bleasby K; Teffera Y; Colletti A; Hafey M; Evers R; Dean DC; Magriotis PA; Lanza TJ; Lin LS; Hagmann WK; Baillie TA Xenobiotica; 2008 Feb; 38(2):223-37. PubMed ID: 18197560 [TBL] [Abstract][Full Text] [Related]
2. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans. Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871 [TBL] [Abstract][Full Text] [Related]
3. Organic Anion-Transporting Polypeptide and Efflux Transporter-Mediated Hepatic Uptake and Biliary Excretion of Cilostazol and Its Metabolites in Rats and Humans. Wang C; Huo X; Wang C; Meng Q; Liu Z; Sun P; Cang J; Sun H; Liu K J Pharm Sci; 2017 Sep; 106(9):2515-2523. PubMed ID: 28535976 [TBL] [Abstract][Full Text] [Related]
4. Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide. Ishiguro N; Maeda K; Saito A; Kishimoto W; Matsushima S; Ebner T; Roth W; Igarashi T; Sugiyama Y Drug Metab Dispos; 2008 Apr; 36(4):796-805. PubMed ID: 18180273 [TBL] [Abstract][Full Text] [Related]
5. Specific Inhibition of the Distribution of Lobeglitazone to the Liver by Atorvastatin in Rats: Evidence for a Rat Organic Anion Transporting Polypeptide 1B2-Mediated Interaction in Hepatic Transport. Yim CS; Jeong YS; Lee SY; Pyeon W; Ryu HM; Lee JH; Lee KR; Maeng HJ; Chung SJ Drug Metab Dispos; 2017 Mar; 45(3):246-259. PubMed ID: 28069721 [TBL] [Abstract][Full Text] [Related]
6. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human. Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907 [TBL] [Abstract][Full Text] [Related]
7. Rate-Determining and Rate-Limiting Steps in the Clearance and Excretion of a Potent and Selective p21-Activated Kinase Inhibitor: A Case Study of Rapid Hepatic Uptake and Slow Elimination in Rat. Fan PW; Chen JZ; Allan Jaochico M; La H; Liu N; Mulder T; Cass RT; Durk M; Messick K; Valle N; Liu S; Lee W; Crawford JJ; Rudolf J; Murray LJ; Cyrus Khojasteh S; Wright M Drug Metab Lett; 2016; 10(2):91-100. PubMed ID: 27063863 [TBL] [Abstract][Full Text] [Related]
8. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233 [TBL] [Abstract][Full Text] [Related]
9. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor. Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513 [TBL] [Abstract][Full Text] [Related]
10. Saturation of multidrug-resistant protein 2 (mrp2/abcc2)-mediated hepatobiliary secretion: nonlinear pharmacokinetics of a heterocyclic compound in rats after intravenous bolus administration. Hu Y; Sampson KE; Heyde BR; Mandrell KM; Li N; Zutshi A; Lai Y Drug Metab Dispos; 2009 Apr; 37(4):841-6. PubMed ID: 19139164 [TBL] [Abstract][Full Text] [Related]
11. Identification of the transporters involved in the hepatobiliary transport and intestinal efflux of methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) glucuronide, a pharmacologically active metabolite of S-8921. Sakamoto S; Kusuhara H; Horie K; Takahashi K; Baba T; Ishizaki J; Sugiyama Y Drug Metab Dispos; 2008 Aug; 36(8):1553-61. PubMed ID: 18474677 [TBL] [Abstract][Full Text] [Related]
12. Impact of quercetin‑induced changes in drug‑metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in rats. Liu Y; Luo X; Yang C; Yang T; Zhou J; Shi S Mol Med Rep; 2016 Oct; 14(4):3073-85. PubMed ID: 27510982 [TBL] [Abstract][Full Text] [Related]
13. OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker. Nakagomi-Hagihara R; Nakai D; Kawai K; Yoshigae Y; Tokui T; Abe T; Ikeda T Drug Metab Dispos; 2006 May; 34(5):862-9. PubMed ID: 16501004 [TBL] [Abstract][Full Text] [Related]
14. Prediction of pharmacokinetic profile of valsartan in humans based on in vitro uptake-transport data. Poirier A; Cascais AC; Funk C; Lavé T Chem Biodivers; 2009 Nov; 6(11):1975-87. PubMed ID: 19937834 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo correlation of the inhibitory effect of cyclosporin A on the transporter-mediated hepatic uptake of cerivastatin in rats. Shitara Y; Hirano M; Adachi Y; Itoh T; Sato H; Sugiyama Y Drug Metab Dispos; 2004 Dec; 32(12):1468-75. PubMed ID: 15550721 [TBL] [Abstract][Full Text] [Related]
16. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. Hagenbuch N; Reichel C; Stieger B; Cattori V; Fattinger KE; Landmann L; Meier PJ; Kullak-Ublick GA J Hepatol; 2001 Jun; 34(6):881-7. PubMed ID: 11451172 [TBL] [Abstract][Full Text] [Related]
17. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs. Beconi MG; Reed JR; Teffera Y; Xia YQ; Kochansky CJ; Liu DQ; Xu S; Elmore CS; Ciccotto S; Hora DF; Stearns RA; Vincent SH Drug Metab Dispos; 2007 Apr; 35(4):525-32. PubMed ID: 17220241 [TBL] [Abstract][Full Text] [Related]
18. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists. Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200 [TBL] [Abstract][Full Text] [Related]
19. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan. Kobayashi M; Nakanishi T; Nishi K; Higaki Y; Okudaira H; Ono M; Tsujiuchi T; Mizutani A; Nishii R; Tamai I; Arano Y; Kawai K Nucl Med Biol; 2014 Apr; 41(4):338-42. PubMed ID: 24607436 [TBL] [Abstract][Full Text] [Related]
20. The involvement of organic anion transporting polypeptide in the hepatic uptake of telmisartan in rats: PET studies with [¹¹C]telmisartan. Takashima T; Hashizume Y; Katayama Y; Murai M; Wada Y; Maeda K; Sugiyama Y; Watanabe Y Mol Pharm; 2011 Oct; 8(5):1789-98. PubMed ID: 21812443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]